Marker Therapeutics is trading at $1.00, up +5.22%, with no new company-specific announcement reported for October 9.
- Shares closed October 8 at $0.95; the latest company press release listed is dated September 22.
- U.S. futures were higher as oil prices fell and AI-investment concerns eased, with markets positioned for a rebound after recent losses.
- This backdrop may be contributing, but available reporting does not directly link it to Marker Therapeutics’ move.